FFF Reduces Risk for Flu Vaccine Providers

Order 100% Returnable Influenza Vaccine Now!

Protect patients from influenza now, without the risks of running out of vaccine or having unused doses.

This distribution innovation is intended to help reduce the financial burden on vaccine providers and, consequently, encourage every possible effort to meet the CDC guidelines* for vaccination throughout the flu season.

FFF's unprecedented 100% returnable product policy includes any orders placed with FFF Enterprises for Novartis Vaccines FLUVIRIN^® Influenza Virus Vaccine 10-dose vials and pre-filled syringes under the following conditions:

• Applies to Novartis Vaccines FLUVIRIN^® Influenza Virus Vaccines purchased directly with FFF for delivery on or after Tuesday, October 16, 2007.
• Returns will be accepted of all unopened, full vials and unopened, full packages of pre-filled syringes that meet our standard return goods criteria, including product that has been properly handled and stored to assure maintenance of its integrity. Such returns will be accepted through April 15, 2008.
  

Please note: FLUVIRIN^® 10-dose vials are available now for next-day delivery.  FLUVIRIN^® is indicated for patients 4 years of age and older, allowing you to treat the majority of your patients with one product brand. 90-day payment terms will be established for all new FLUVIRIN^® orders.

Place your 100% returnable order today for next-day delivery by calling FFF’s Wow! Customer Care Team at
800-843-7477.

*From the CDC: Vaccination efforts should continue throughout the season, because the duration of the influenza season varies, and influenza might not appear in certain communities until February or March. Providers should offer influenza vaccine routinely, and organized vaccination campaigns should continue throughout the influenza season, including after influenza activity has begun in the community. Vaccine administered in December or later, even if influenza activity has already begun, is likely to be beneficial in the majority of influenza seasons. The majority of aduIts have antibody protection against influenza virus infection within 2 weeks after vaccination.

From the Houston Chronicle
Save a Little, but Lose Big Online

From abc7News.com
IVIG Intravenous Therapy a Life Saver for Many

From Chicago Daily Herald
Five Reasons to Get a Flu Shot (Other Than the Obvious One)

From CSL Behring
L-Proline Stabilizer Used in the Intravenous Immunoglobulin Product Privigen® Shows No Neurological Side Effects Compared with Currently Used Stabilizers

From sanofi-aventis
Sanofi Pasteur Initiated Phase II Trial of Cell Culture-based Seasonal Influenza Vaccine

From CMS.gov
Medicare Final Rule Announces 2008 Physician Fees and Reforms for Accurate Payments and Quality

From WCBS-TV New York
What's in the Bottle? Your Pharmacy Might Not Know

From CDC
Nation′s Influenza Vaccine Supplies Continue to Increase;
CDC Advises Broadening of Vaccination Efforts